Hims & Hers’ Labs app (Hims & Hers)

Hims & Hers launches blood test analysis product

Hims expects to introduce more specs, including at-home testing devices, over time.

Hims & Hers announced the launch of a lab-testing product it says will analyze bloodwork and suggest custom health plans.

The product, called “Labs,” will allow users to upload bloodwork and suggest “doctor-developed action plans,” which may include suggestions for medication that is sold by Hims or its partners.

The product has two tiers: a base plan that costs $199 a year or an advanced plan for $499 a year. The base plan comes with one blood draw a year, while the advanced comes with two and measures more biomarkers. Similar products are sold by startups like Function Health and Lifeforce.

The testing is being done through a partnership with Quest Diagnostics. Hims expects to introduce more specs, including at-home testing devices, over time. The company acquired an at-home blood-testing facility, Trybe Labs, in February, which is being used to onboard patients in Hims’ new hormone treatment segments.

Hims was down about 6% leading up to the announcement and stayed around there after the announcement.

The announcement comes as Hims investors have grown increasingly gloomy, with many momentum stocks like Hims having pulled back sharply of late. Hims is down 40% since October 15, when it announced it would expand its product lineup to offer menopause treatments.

The company has been looking for ways to spark sales growth as its core sexual health business slows down and its ability to sell weight-loss treatments remains on shaky ground. Its expansion into hormone treatments has sparked short-lived rallies, but other signs, like executive stock sales and the sudden departure of its newly appointed chief operating officer, Amazon alum Nader Kabbani, have given investors pause.

Matt Phillips3h

Sandisk, memory chip stocks slump after Japanese competitor reports weak numbers

High-flying shares of tech hardware firms like Sandisk, Seagate Technology Holdings, and Western Digital — which make products to deal with the deluge of information and data expected to be produced by the AI database build-out — dropped Thursday after a Japanese competitor, Kioxia Holdings, reported a lackluster set of quarterly numbers.

These stocks are also suffering as part of a general drawdown in AI data center and data center-adjacent stocks Thursday amid a flurry of stories on the sector, all of which have, at their heart, the growing sense of the lack of transparency and uncertainty about supply, demand, available resources, costs, and short-term losses swirling around the boom.

Seagate Stock Is Getting Crushed. Here’s What Spooked the Market.

$4B

Max Knoblauch4h

We already knew Disney had a hit with its live-action “Lilo & Stitch” earlier this year — the film earned more than 10x its reported budget at the global box office. But for Disney, it also massively fueled merch sales.

“Retail sales for Stitch from our Consumer Products business also continues to grow, eclipsing $4 billion in fiscal 2025,” Disney CEO Bob Iger said. That’s up more than 50% from a reported $2.6 billion in Stitch merch sales in fiscal 2024.

To put that $4 billion sales figure in context, Harley Davidson sold about the same amount in motorcycles, parts and accessories, and apparel combined last year. The amount Disney made on Stitch toys, blankets, and clothes is roughly equal to the market cap of Shake Shack. Not too shabby for a 23-year-old piece of intellectual property.

Matt Phillips4h

Flutter dives on guidance cut, flurry of analyst price target cuts

Flutter Entertainment, the parent of top US online sports betting app FanDuel, tumbled in early trading after it cut revenue guidance as part of a disappointing earnings report issued yesterday after the close.

The company also surprised some on Wall Street with the amount it plans to spend — $45 million in Q4 and between $200 million and $300 million next year — on its own prediction markets push, as the sports betting business attempts to fend off emerging competitive pressure.

Bank of America analysts, who recently downgraded their rating of the stock to “neutral,” said such spending “is materially higher than our and investor expectation. Strategically, we think this step-up investment could be warranted given the total addressable market, but also confirms we are entering an investment phase” for the industry that may be “a tough period for [online sports betting] operator profitability.”

According to FactSet data, 14 analysts have trimmed their Flutter price targets since the report was released, taking the consensus 12- to 18-month bogey for the stock from over $330 to less than $320, which is still a more than 50% premium to the market — and widening by the minute.